Overview

Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine the effectiveness and safety of an annual intravenous treatment of zoledronic acid for the treatment of osteoporosis in men. All patients will receive calcium and vitamin D supplements.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Diphosphonates
Zoledronic Acid